adMare Bio Innovations logo

adMare Bio Innovations

North America, British Columbia, Canada, Vancouver

Description

adMare Bio innovations is a global life sciences venture, building Canadian life sciences from sea to sea.

Investor Profile

adMare Bio Innovations has backed more than 7 startups, with 3 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in Canada, France, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (29%)
  • Seed (29%)
  • Series C (14%)
  • Series A (14%)
  • Convertible Note (14%)

Country Focus

  • Canada (71%)
  • France (14%)
  • United Kingdom (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does adMare Bio Innovations frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 4
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Amorchem
North America, Quebec, Canada, Montréal
Co-Investments: 2
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 3
Investissement Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 3
Viva BioInnovator
Asia, Shanghai, China, Shanghai
Co-Investments: 2

Which angels does adMare Bio Innovations often collaborate with?

JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by adMare Bio Innovations?

Find therapeutics

Quebec, Quebec, Canada

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

BiotechnologyClinical TrialsTherapeutics
Series AJan 9, 2026
Amount Raised: $7,210,445
Thryv Therapeutics

Laval, Quebec, Canada

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

BiotechnologyPrecision MedicineTherapeutics
Series UnknownSep 17, 2025
KisoJi Biotechnology

Laval-ouest, Quebec, Canada

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

BiotechnologyLife ScienceMedicalTherapeutics
Series BDec 2, 2024
Amount Raised: $40,579,533
Epitopea

Cambridge, Cambridgeshire, United Kingdom

Epitopea is a transatlantic cancer immunotherapeutics company.

BiotechnologyLife ScienceTherapeutics
SeedOct 24, 2024
Amount Raised: $31,000,000
Find therapeutics

Quebec, Quebec, Canada

Find therapeutics is operator of a drug discovery and development company intended to emerge with a new therapeutic modality.

Biotechnology
Convertible NoteSep 16, 2024
Amount Raised: $8,095,825
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series COct 17, 2022
Amount Raised: $69,264,701
Domain Therapeutics

Illkirch, Alsace, France

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 10, 2022
Amount Raised: $41,063,697
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BSep 8, 2020
Amount Raised: $35,000,000
Bright Angel Therapeutics

Toronto, Ontario, Canada

Bright Angel Therapeutics is developing new drugs that can prevent or revert the emergence of antifungal resistance.

Biotechnology
SeedDec 3, 2019

Find More Investors Like adMare Bio Innovations

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides